ARCHIVES

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

This article is from The Cancer Letter archive.

Vol. 23 No. 11 | March 21, 1997

Download PDF Visit The Full Archive

Related Articles

Some Tumors Show Partial Response To Drug Combo

January 27, 2006

In Brief: Dewys Asked To Step Down As Prevention Head By Greenwald; Paul Sherlock Of MSK Dies At 56

May 17, 1985

NCAB ‘Incredulous’ Over Proposed Ethics Rules, Bard Members Threaten Resignation In Letter

October 4, 1991

NCI, Rhone-Poulenc Sign Agreement For Taxotere Trials

June 19, 1992

Recurrent Low-Grade Serous Carcinoma Less Responsive To Chemotherapy

March 28, 2008

Early ADT Doesn’t Offer Survival Advantage—ASCO

April 27, 2007